Copyright
©The Author(s) 2003.
World J Gastroenterol. Dec 15, 2003; 9(12): 2695-2697
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2695
Published online Dec 15, 2003. doi: 10.3748/wjg.v9.i12.2695
Table 2 Clinical characteristics of patients infected by geno-type B and C HBV
| Genotype B (n = 43) | Genotype C (n = 88) | P value | |
| Age | 34 (13-67) | 29 (12-68) | 0.14 |
| Male gender (n,%) | 28 (65%) | 47 (53%) | 0.28 |
| Initial ALT (IU/l) | 70 (17-1094) | 77 (18-1122) | 0.60 |
| Follow-up (months) | 38 (18-49) | 39 (18-49) | 0.49 |
| Treatment (n,%) | 0.40 | ||
| Nil | 29 (67%) | 67 (76%) | |
| Lamivudine | 14 (33%) | 21 (24%) |
- Citation: Chan HLY, Wong ML, Hui AY, Chim AML, Tse AML, Hung LCT, Chan FKL, Sung JJY. Hepatitis B virus genotype has no impact on hepatitis B e antigen seroconversion after lamivudine treatment. World J Gastroenterol 2003; 9(12): 2695-2697
- URL: https://www.wjgnet.com/1007-9327/full/v9/i12/2695.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i12.2695